Globus Medical, Inc. Financials

Market Capitalization $12.58 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	149.06
Forward PE	27.02
Price to Sales TTM	$5.08
Price to Book MRQ	$3.09
Enterprise to Revenue	5.01
Enterprise to EBITDA	19.06

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	3.69%
Operating Margin	17.67%
Return on Assets TTM	4.73%
Return on Equity TTM	2.22%

Income Statement

Revenue TTM	$2,478,596,096
Revenue per Share TTM	$18.22
Quarterly Revenue Growth	63.10%
Gross Profit TTM	$1,661,933,952
EBITDA	$464,205,000
Net Income to Common TTM	$91,513,000
Diluted EPS TTM	$0.62
Quarterly Earnings Growth YoY	5094.00%

Balance Sheet

Total Cash MRQ	$694,705,984
Total Cash per Share MRQ	$5.10
Total Debt MRQ	$
Total Debt to Equity MRQ	13.18
Current Ratio MRQ	2.51
Book Value per Share MRQ	$29.94

Cash Flow

Operating Cash Flow TTM	$414,972,992
Levered Free Cash Flow TTM	$473,363,616

GMED Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	113,737,000
Float Shares	112,802,388
Avg 10 Volume	1,576,670
Avg 30 Volume	None
Shares Short	2,489,401
Short Ratio	2.94
Short % of Shares	2.45%
% Held by Insiders	0.74%
% Held by Institutions	98.73%

Stock Price Summary

Beta	1.17
Fifty Two Week Low	$49.33
Fifty Two Week High	$93.67
Fifty Two Week Change	41.25%
Day 50 MA	$84.51
Day 200 MA	$71.50

Dividends and Splits

Forward Annual Dividend Rate	$
Forward Annual Dividend Yield	%
Trailing Annual Dividend Rate	$0.00
Trailing Annual Dividend Yield	0.00%
Payout Ratio	0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date